2004
DOI: 10.1097/01.inf.0000130951.85974.79
|View full text |Cite
|
Sign up to set email alerts
|

Invasive Pneumococcal Infections Among Hospitalized Children in Bamako, Mali

Abstract: IPD is common and frequently fatal among hospitalized children in Mali, but surprisingly little resistance has occurred. Notably, 91% of the serotypes causing IPD in Bamako children are found in the 11-valent pneumococcal conjugate vaccine.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

3
60
3
1

Year Published

2007
2007
2018
2018

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 76 publications
(67 citation statements)
references
References 45 publications
3
60
3
1
Order By: Relevance
“…In Mali, West Africa, children have limited access to health care and are not immunized against S. pneumoniae. Although the rates in Mali were not unlike those in other developing countries, the rates of IPD in hospitalized children in Mali were reported to be higher than those of industrialized nations (3). Furthermore, the case fatality rate due to IPD in hospitalized children in Mali was 23.6%.…”
mentioning
confidence: 92%
See 1 more Smart Citation
“…In Mali, West Africa, children have limited access to health care and are not immunized against S. pneumoniae. Although the rates in Mali were not unlike those in other developing countries, the rates of IPD in hospitalized children in Mali were reported to be higher than those of industrialized nations (3). Furthermore, the case fatality rate due to IPD in hospitalized children in Mali was 23.6%.…”
mentioning
confidence: 92%
“…Streptococcus pneumoniae is the most common cause of bacterial pneumonia in children in developing countries (3,14). Invasive pneumococcal disease (IPD) is also a major cause of morbidity and mortality, particularly in the developing world.…”
mentioning
confidence: 99%
“…51,59 Differences in prevalence of the common infective organisms in patients with sickle cell disease between African and European countries, for example, are crucial to identify since this will dictate the effectiveness of prophylactic measures. Penicillin prophylaxis has played a major role in reducing mortality in developed countries 60 and it is important to find out whether it will be similarly beneficial in African countries where several groups have found that Streptococcus pneumoniae is also a major cause of morbidity and mortality 61,62 whereas others report that it is less common. 63 The growth of research collaborations in sickle cell disease between developing countries and well resourced countries 31,32,[61][62][63] has recently been highlighted as an important tool for improving clinical and diagnostic facilities in developing countries as well as advancing our knowledge of disease pathogenesis.…”
mentioning
confidence: 99%
“…One set included 443 isolates obtained from blood cultures of 431 febrile patients at l'Hôpital Gabriel Touré in Bamako, Mali, in the course of systematic surveillance for bacteremia and invasive bacterial disease among patients younger than 16 years of age with fever, who were admitted to the hospital or seen in the emergency room (6,27). Strains initially identified in the clinical microbiology laboratory of the Centre pour le Développement des Vaccins, Bamako, Mali (CVD-Mali), as Salmonella serotype Typhi, Paratyphi A, or Paratyphi B or as Salmonella species were shipped to CVD-Baltimore for bacteriological confirmation.…”
mentioning
confidence: 99%